Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis C

Clinical trial condition

Hepatitis C

Explore clinical trials studying Hepatitis C. Study availability and eligibility vary by location and protocol.

1,296 public trials 40 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis C trial results

Completed

A Study of of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection

NCT02966795

Conditions: Blood-Borne Infections, Bronchial Diseases, Bronchiolitis, +20 more
Locations: Research & Education, Inc. /ID# 157042 San Diego, California, United States

Kaiser Permanente /ID# 157044 San Diego, California, United States

Zuckerberg San Francisco Gener /ID# 157040 San Francisco, California, United States

Cedars-Sinai Medical Center - West Hollywood /ID# 157045 West Hollywood, California, United States

View all 25 locations

View Trial Details

Completed

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection

NCT02243293

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +16 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection

NCT01685203

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Hepatitis C Virus Genotype 1b-Infected Adults

NCT02582632

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +10 more
Locations: Not specified

View Trial Details

Completed

Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT- 267 (ABT-450/r/ABT-267) in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus (HCV) Infection

NCT02023112

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 Infection

NCT02640157

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +17 more
Locations: Not specified

View Trial Details

Completed

Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt

NCT02247401

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Accelerated Pre-treatment Evaluation for HCV Infected Persons Who Inject Drugs

NCT02755402

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Centre hospitalier de l'Université de Montréal Montreal, Quebec, Canada

View Trial Details

Completed

Truenat™ HCV RNA Assay Evaluation

NCT04236973

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Aarhus University Hospital Aarhus, Denmark

St Paul's Hospital Millennium Medical College Addis Ababa, Ethiopia

National Centre for Diseases Control Tbilisi, Georgia

HIV-NAT Thai Red Cross AIDS Research Centre Bangkok, Thailand

View Trial Details

Completed

Understanding and Intervening With Heavy Drinking Among Patients With HIV and HCV

NCT03652675

Conditions: Acquired Immunodeficiency Syndrome, Alcohol Drinking, Alcohol Use Disorder, +30 more
Locations: NewYork-Presbyterian / Columbia University Medical Center New York, United States

View Trial Details